Treatment Information

Back

Colon Cancer treatment details. Chemotherapy.

Dana–Farber Cancer Institute , Boston, MA, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Boston, MA
Treatments:ChemotherapyHospital:Dana–Farber Cancer Institute
Drugs:Journal:Link
Date:May 2015

Description:

Patients:
This phase 3 study involved 534 previously treated metastatic colorectal cancer patients. The median patient age was 63 years and 61% were male.

Treatment:
Patients received chemotherapy with TAS-102.

Toxicities:
There was one reported treatment-related death due to sepsis. Grade 3 or higher decreased appetite, fatigue, and stomatitis (inflammation of the stomach lining) were also reported.

Results:
The median overall survival was 7.1 months.

Support:
This study was supported by Taiho Pharmaceutical, makers of the study drug.

Correspondence: Dr. Robert J. Mayer; email: N/A



Back